These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27708194)

  • 1. Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells.
    Chapin RE; Ball DJ; Radi ZA; Kumpf SW; Koza-Taylor PH; Potter DM; Mark Vogel W
    Toxicol Sci; 2017 Jan; 155(1):148-156. PubMed ID: 27708194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.
    Radi ZA; Vogel WM; Bartholomew PM; Koza-Taylor P; Papanikolaou A; Wisialowski T; Nambiar P; Ball DJ
    Regul Toxicol Pharmacol; 2017 Dec; 91():93-102. PubMed ID: 29074274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
    Kanzaki M; Morris PL
    Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations.
    McInnes IB; Byers NL; Higgs RE; Lee J; Macias WL; Na S; Ortmann RA; Rocha G; Rooney TP; Wehrman T; Zhang X; Zuckerman SH; Taylor PC
    Arthritis Res Ther; 2019 Aug; 21(1):183. PubMed ID: 31375130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS.
    Calama E; Ramis I; Domènech A; Carreño C; De Alba J; Prats N; Miralpeix M
    Pulm Pharmacol Ther; 2017 Apr; 43():60-67. PubMed ID: 28087469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
    Ibrahim SSA; Salama MA; Selima E; Shehata RR
    Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged in vivo administration of testosterone-enanthate, the widely used and abused anabolic androgenic steroid, disturbs prolactin and cAMP signaling in Leydig cells of adult rats.
    Bjelic MM; Stojkov NJ; Radovic SM; Baburski AZ; Janjic MM; Kostic TS; Andric SA
    J Steroid Biochem Mol Biol; 2015 May; 149():58-69. PubMed ID: 25603467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function.
    De Vries LCS; Duarte JM; De Krijger M; Welting O; Van Hamersveld PHP; Van Leeuwen-Hilbers FWM; Moerland PD; Jongejan A; D'Haens GR; De Jonge WJ; Wildenberg ME
    Inflamm Bowel Dis; 2019 Mar; 25(4):647-660. PubMed ID: 30668755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
    Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
    Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats.
    Gertel S; Mahagna H; Karmon G; Watad A; Amital H
    Clin Immunol; 2017 Nov; 184():77-81. PubMed ID: 28461107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor.
    Elwood F; Witter DJ; Piesvaux J; Kraybill B; Bays N; Alpert C; Goldenblatt P; Qu Y; Ivanovska I; Lee HH; Chiu CS; Tang H; Scott ME; Deshmukh SV; Zielstorff M; Byford A; Chakravarthy K; Dorosh L; Rivkin A; Klappenbach J; Pan BS; Kariv I; Dinsmore C; Slipetz D; Dandliker PJ
    J Pharmacol Exp Ther; 2017 May; 361(2):229-244. PubMed ID: 28193636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
    Gao W; McGarry T; Orr C; McCormick J; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Jan; 75(1):311-5. PubMed ID: 26353790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular mechanisms of low dose prolactin potentiation of testicular development in cockerels.
    Zhu HX; Liu XQ; Cai LP; Lei MM; Chen R; Yan JS; Yu JN; Shi ZD
    Domest Anim Endocrinol; 2019 Oct; 69():51-61. PubMed ID: 31299561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes.
    Srivastava A; Ståhle M; Pivarcsi A; Sonkoly E
    Acta Derm Venereol; 2018 Aug; 98(8):772-775. PubMed ID: 29738047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common and specific effects of the two major forms of prolactin in the rat testis.
    Williams VL; DeGuzman A; Dang H; Kawaminami M; Ho TW; Carter DG; Walker AM
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1795-803. PubMed ID: 17911340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.
    Kubo S; Yamaoka K; Kondo M; Yamagata K; Zhao J; Iwata S; Tanaka Y
    Ann Rheum Dis; 2014 Dec; 73(12):2192-8. PubMed ID: 24013646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and MA-10 Leydig cell steroidogenesis: biphasic effects of prolactin and signal transduction.
    Weiss-Messer E; Ber R; Barkey RJ
    Endocrinology; 1996 Dec; 137(12):5509-18. PubMed ID: 8940378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.